FIGURE

Fig. 7

ID

ZDB-FIG-210307-29

Publication

Ni et al., 2021 - ELAVL1a is an immunocompetent protein that protects zebrafish embryos from bacterial infection

Other Figures

All Figure Page

Back to All Figure Page

Fig. 7

Diagram showing zebrafish ELAVL1a truncation and their antibacterial activities and binding to LPS and LTA.

a Diagram showing zebrafish ELAVL1a truncation. b Antibacterial activity of rE_181–242 against M. luteus and E. coli. c, d, e Interaction of rE_181–242 (c), rE_1–180 (d) and rE_243–324 (e) with LTA and LPS revealed by ELISA. f The in vivo bioactivity of rE_1–180, rE_181–242, and rE_243–324. The early (8-cell stage) embryos were first microinjected with PBS, BSA, anti-β-actin antibody (AcAb), anti ELAVL1a antibody (ELAVL1aAb), rE_1–180, rE_181–242, rE_243–324 and rELAVL1a, then challenged by injection with live A. hydrophila. The development of the embryos was observed and the cumulative mortality rate was calculated at 24 h after injection. All data were expressed as mean values ± S.D. (n = 3). The data are from three independent experiments performed in triplicate. The bars represent the mean ± SD. The significance of the difference was determined by one-way ANOVA. *p < 0.05. AcAb, anti-β-actin antibody; ELAVL1aAb, mouse anti-ELAVL1a antibody.

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Commun Biol